WELCOME TO The data analytics REPORT
Data Management for Artificial Intelligence
May 20, 2019
I'm For Real
Enter your details once to access all our information and resources
Mimic your production data to create de-identified, realistic, and safe data for your test environments.
whitePaper | March 29, 2023
Migrating to a new analytics environment can be a complex, timeconsuming and resource-intensive undertaking. Significant investments have been sunk into existing analytic environments, and migrating to a new platform can involve months of effort. When organizations go to this level of effort and expense, ideally, they should achieve more than simply migrating the existing environment. A migration provides an excellent opportunity to look to the future, rethink the environment, and deliver new capabilities to the business that can improve efficiency and serve as a source of competitive advantage.
whitePaper | May 6, 2022
Every organization today recognizes the strategic value of generating actionable insights from their enterprise data.
whitePaper | July 12, 2022
In many ways, 2022 has been an exercise in dealing with the reeling of the Covid-19 pandemic. All over the world, supply chain issues have led to a myriad of challenges for enterprises, leading to deep shifts in how we do business and unraveling many of our assumptions about how society operates.
whitePaper | September 6, 2022
Data is the heartbeat of the modern enterprise. Technology has progressed to the point that data-driven decision making is the norm and data literacy is often prized above all other skills.
whitePaper | May 15, 2023
Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings.
Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.
whitePaper | October 10, 2022
Companies undergoing digital transformation must make data available to all stakeholders. However, outdated security and governance tools can prevent companies from freeing their data without opening themselves up to new risks.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE